MRI Safe Neurostimulation Systems Market by Product Type and Application - Global Industry Analysis & Forecast to 2027
Published On : June 2022 Pages : 170 Category: Medical Devices Report Code : HC063836
MRI Safe Neurostimulation Systems Market by Product Type (Implantable Neurostimulators, Transcutaneous Neurostimulators) Application (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sensory Nerve Stimulation, Intracranial Stimulation, Motor Cortex Stimulation) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The MRI Safe Neurostimulation Systems Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Nervous system exercises in humans can be regulated with the assistance of non-intrusive and obtrusive techniques which incorporate transcranial attractive incitement and microelectrodes individually. The modulation of exercises identified with the sensory system is in fact named as neurostimulation. Neurostimulation can be characterized as deliberate tweak of the exercises of the sensory system. It is an electromagnetic way to deal with neuromodulation.
Drivers and Restraints
The augmentation in the aged populace combined with the expansion in neurological issue is the prime reasons which are foreseen to drive the worldwide MRI safe neurostimulation systems market. Development in the use in healthcare and biotechnology section is additionally a noteworthy reason fuelling the development of the market.
Regional Insights
In the North America locale, United States have the biggest share of the market in the worldwide MRI Safe Neurostimulation Systems Market because of changing way of life of individuals combined with rising aged populace.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Sorin
- AADCO Medical Inc
- Biotronik
- Nevro Corporation
- Codman & Shurtleff’s
- Boston Scientific
- Cyberonics, Inc
- St. Jude Medical
- Medtronic
- Neuronetics
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· MRI Safe Neurostimulation Systems Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Implantable Neurostimulators
o Transcutaneous Neurostimulators
· MRI Safe Neurostimulation Systems Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Spinal Cord Stimulation
o Deep Brain Stimulation
o Vagus Nerve Stimulation
o Sensory Nerve Stimulation
o Intracranial Stimulation
o Motor Cortex Stimulation
· MRI Safe Neurostimulation Systems Market, By Key Players
o Sorin
o AADCO Medical Inc
o Biotronik
o Nevro Corporation
o Codman & Shurtleff’s
o Boston Scientific
o Cyberonics, Inc
o St. Jude Medical
o Medtronic
o Neuronetics
· MRI Safe Neurostimulation Systems Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America MRI Safe Neurostimulation Systems Market, By Country
o U.S. MRI Safe Neurostimulation Systems Market
o Canada MRI Safe Neurostimulation Systems Market
o Mexico MRI Safe Neurostimulation Systems Market
o Europe
§ Europe MRI Safe Neurostimulation Systems Market, By Country
o Germany MRI Safe Neurostimulation Systems Market
o UK MRI Safe Neurostimulation Systems Market
o France MRI Safe Neurostimulation Systems Market
o Russia MRI Safe Neurostimulation Systems Market
o Italy MRI Safe Neurostimulation Systems Market
o Rest of Europe MRI Safe Neurostimulation Systems Market
o Asia-Pacific
§ Asia-Pacific MRI Safe Neurostimulation Systems Market, By Country
o China MRI Safe Neurostimulation Systems Market
o Japan MRI Safe Neurostimulation Systems Market
o South Korea MRI Safe Neurostimulation Systems Market
o India MRI Safe Neurostimulation Systems Market
o Southeast Asia MRI Safe Neurostimulation Systems Market
o Rest of Asia-Pacific MRI Safe Neurostimulation Systems Market
o South America
§ South America MRI Safe Neurostimulation Systems Market
o Brazil MRI Safe Neurostimulation Systems Market
o Argentina MRI Safe Neurostimulation Systems Market
o Columbia MRI Safe Neurostimulation Systems Market
o Rest of South America MRI Safe Neurostimulation Systems Market
o Middle East and Africa
§ Middle East and Africa MRI Safe Neurostimulation Systems Market
o Saudi Arabia MRI Safe Neurostimulation Systems Market
o UAE MRI Safe Neurostimulation Systems Market
o Egypt MRI Safe Neurostimulation Systems Market
o Nigeria MRI Safe Neurostimulation Systems Market
o South Africa MRI Safe Neurostimulation Systems Market
o Rest of MEA MRI Safe Neurostimulation Systems Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. MRI Safe Neurostimulation Systems Market, By Product Type
5.1. Introduction
5.2. Global MRI Safe Neurostimulation Systems Revenue and Market Share by Product Type (2017-2027)
5.2.1. Global MRI Safe Neurostimulation Systems Revenue and Revenue Share by Product Type (2017-2027)
5.3. Implantable Neurostimulators
5.3.1. Global Implantable Neurostimulators Revenue and Growth Rate (2017-2027)
5.4. Transcutaneous Neurostimulators
5.4.1. Global Transcutaneous Neurostimulators Revenue and Growth Rate (2017-2027)
6. MRI Safe Neurostimulation Systems Market, By Application
6.1. Introduction
6.2. Global MRI Safe Neurostimulation Systems Revenue and Market Share by Application (2017-2027)
6.2.1. Global MRI Safe Neurostimulation Systems Revenue and Revenue Share by Application (2017-2027)
6.3. Spinal Cord Stimulation
6.3.1. Global Spinal Cord Stimulation Revenue and Growth Rate (2017-2027)
6.4. Deep Brain Stimulation
6.4.1. Global Deep Brain Stimulation Revenue and Growth Rate (2017-2027)
6.5. Vagus Nerve Stimulation
6.5.1. Global Vagus Nerve Stimulation Revenue and Growth Rate (2017-2027)
6.6. Sensory Nerve Stimulation
6.6.1. Global Sensory Nerve Stimulation Revenue and Growth Rate (2017-2027)
6.7. Intracranial Stimulation
6.7.1. Global Intracranial Stimulation Revenue and Growth Rate (2017-2027)
6.8. Motor Cortex Stimulation
6.8.1. Global Motor Cortex Stimulation Revenue and Growth Rate (2017-2027)
7. MRI Safe Neurostimulation Systems Market, By Region
7.1. Introduction
7.2. Global MRI Safe Neurostimulation Systems Revenue and Market Share by Regions
7.2.1. Global MRI Safe Neurostimulation Systems Revenue by Regions (2017-2027)
7.3. North America MRI Safe Neurostimulation Systems by Countries
7.3.1. North America MRI Safe Neurostimulation Systems Revenue and Growth Rate (2017-2027)
7.3.2. North America MRI Safe Neurostimulation Systems Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe MRI Safe Neurostimulation Systems by Countries
7.4.1. Europe MRI Safe Neurostimulation Systems Revenue and Growth Rate (2017-2027)
7.4.2. Europe MRI Safe Neurostimulation Systems Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific MRI Safe Neurostimulation Systems by Countries
7.5.1. Asia-Pacific MRI Safe Neurostimulation Systems Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific MRI Safe Neurostimulation Systems Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America MRI Safe Neurostimulation Systems by Countries
7.6.1. South America MRI Safe Neurostimulation Systems Revenue and Growth Rate (2017-2027)
7.6.2. South America MRI Safe Neurostimulation Systems Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa MRI Safe Neurostimulation Systems by Countries
7.7.1. Middle East and Africa MRI Safe Neurostimulation Systems Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa MRI Safe Neurostimulation Systems Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Sorin
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. AADCO Medical Inc
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Biotronik
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Nevro Corporation
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Codman & Shurtleff’s
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Boston Scientific
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Cyberonics, Inc
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. St. Jude Medical
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Medtronic
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Neuronetics
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.1. Global MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. MRI Safe Neurostimulation Systems Market Forecast by Regions (2017-2027)
9.2.1. North America MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.1.1. United States MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.1.2. Canada MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.1.3. Mexico MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.2. Europe MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.2.1. Germany MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.2.2. France MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.2.3. UK MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.2.4. Russia MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.2.5. Italy MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.2.6. Rest of Europe MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.3. Asia-Pacific MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.3.1. China MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.3.2. Japan MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.3.3. Korea MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.3.4. India MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.3.5. Southeast Asia MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.4. South America MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.4.1. Brazil MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.4.2. Argentina MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.4.3. Columbia MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.4.4. Rest of South America MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.5. Middle East and Africa MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.5.3. Egypt MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.5.4. Nigeria MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.5.5. South Africa MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.5.6. Turkey MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa MRI Safe Neurostimulation Systems Market Forecast (2017-2027)
9.3. MRI Safe Neurostimulation Systems Market Forecast by Product Type (2017-2027)
9.3.1. MRI Safe Neurostimulation Systems Forecast by Product Type (2017-2027)
9.3.2. MRI Safe Neurostimulation Systems Market Share Forecast by Product Type (2017-2027)
9.4. MRI Safe Neurostimulation Systems Market Forecast by Application (2017-2027)
9.4.1. MRI Safe Neurostimulation Systems Forecast by Application (2017-2027)
9.4.2. MRI Safe Neurostimulation Systems Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure France MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure China MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure India MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa MRI Safe Neurostimulation Systems Revenue (Million USD) and Growth Rate (2017-2025)
Table Global MRI Safe Neurostimulation Systems Revenue and Revenue Share by Product Type (2017-2018)
Figure Global Implantable Neurostimulators Revenue and Growth Rate (2017-2018)
Figure Global Transcutaneous Neurostimulators Revenue and Growth Rate (2017-2018)
Table Global MRI Safe Neurostimulation Systems Revenue and Revenue Share by Application (2017-2018)
Figure Global Spinal Cord Stimulation Revenue and Growth Rate (2017-2018)
Figure Global Deep Brain Stimulation Revenue and Growth Rate (2017-2018)
Figure Global Vagus Nerve Stimulation Revenue and Growth Rate (2017-2018)
Figure Global Sensory Nerve Stimulation Revenue and Growth Rate (2017-2018)
Figure Global Intracranial Stimulation Revenue and Growth Rate (2017-2018)
Figure Global Motor Cortex Stimulation Revenue and Growth Rate (2017-2018)
Table Global MRI Safe Neurostimulation Systems Revenue by Regions (2017-2018)
Figure North America MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure North America MRI Safe Neurostimulation Systems Revenue and Growth Rate (2017-2018)
Figure North America MRI Safe Neurostimulation Systems by Countries (2017-2018)
Figure North America MRI Safe Neurostimulation Systems Revenue (Million USD) by Countries (2017-2018)
Figure United States MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure United States MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Canada MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Mexico MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Europe MRI Safe Neurostimulation Systems Revenue and Growth Rate (2017-2018)
Figure Europe MRI Safe Neurostimulation Systems by Countries (2017-2018)
Figure Europe MRI Safe Neurostimulation Systems Revenue (Million USD) by Countries (2017-2018)
Figure Germany MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Germany MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure France MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure UK MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Russia MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Italy MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Rest of Europe MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Asia-Pacific MRI Safe Neurostimulation Systems Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific MRI Safe Neurostimulation Systems by Countries (2017-2018)
Figure Asia-Pacific MRI Safe Neurostimulation Systems Revenue (Million USD) by Countries (2017-2018)
Figure China MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure China MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Japan MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Korea MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure India MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Southeast Asia MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Rest of Asia-Pacific MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure South America MRI Safe Neurostimulation Systems Revenue and Growth Rate (2017-2018)
Figure South America MRI Safe Neurostimulation Systems by Countries (2017-2018)
Figure South America MRI Safe Neurostimulation Systems Revenue (Million USD) by Countries (2017-2018)
Figure Brazil MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Brazil MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Argentina MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Columbia MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Rest of South America MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Middle East and Africa MRI Safe Neurostimulation Systems Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa MRI Safe Neurostimulation Systems by Countries (2017-2018)
Figure Middle East and Africa MRI Safe Neurostimulation Systems Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Saudi Arabia MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure United Arab Emirates MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Egypt MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Nigeria MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure South Africa MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Turkey MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa MRI Safe Neurostimulation Systems Growth Rate (2017-2018)
Figure Rest of Middle East and Africa MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2017-2018)
Table Sorin MRI Safe Neurostimulation Systems Financial Overview
Table AADCO Medical Inc MRI Safe Neurostimulation Systems Financial Overview
Table Biotronik MRI Safe Neurostimulation Systems Financial Overview
Table Nevro Corporation MRI Safe Neurostimulation Systems Financial Overview
Table Codman & Shurtleff’s MRI Safe Neurostimulation Systems Financial Overview
Table Boston Scientific MRI Safe Neurostimulation Systems Financial Overview
Table Cyberonics, Inc MRI Safe Neurostimulation Systems Financial Overview
Table St. Jude Medical MRI Safe Neurostimulation Systems Financial Overview
Table Medtronic MRI Safe Neurostimulation Systems Financial Overview
Table Neuronetics MRI Safe Neurostimulation Systems Financial Overview
Figure Global MRI Safe Neurostimulation Systems Revenue (Millions USD) and Growth Rate (2018-2025)
Table MRI Safe Neurostimulation Systems Market Forecast by Regions (2018-2025)
Figure North America MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure United States MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Canada MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Mexico MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Europe MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Germany MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure France MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure UK MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Russia MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Italy MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Rest of Europe MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Asia-Pacific MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure China MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Japan MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Korea MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure India MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Southeast Asia MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Rest of Asia-Pacific MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure South America MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Brazil MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Argentina MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Columbia MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Rest of South America MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Middle East and Africa MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Saudi Arabia MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure United Arab Emirates MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Egypt MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Nigeria MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure South Africa MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Turkey MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Rest of Middle East and Africa MRI Safe Neurostimulation Systems Market Forecast (2018-2025)
Figure Global MRI Safe Neurostimulation Systems Forecast by Product Type (2018-2025)
Figure Global MRI Safe Neurostimulation Systems Market Share Forecast by Product Type (2018-2025)
Figure Global MRI Safe Neurostimulation Systems Forecast by Product Type (2018-2025)
Figure Global MRI Safe Neurostimulation Systems Forecast by Application (2018-2025)
Figure Global MRI Safe Neurostimulation Systems Market Share Forecast by Application (2018-2025)
Figure Global MRI Safe Neurostimulation Systems Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|